E Tatarczyńska

2.8k total citations
90 papers, 2.4k citations indexed

About

E Tatarczyńska is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, E Tatarczyńska has authored 90 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cellular and Molecular Neuroscience, 40 papers in Molecular Biology and 37 papers in Organic Chemistry. Recurrent topics in E Tatarczyńska's work include Neurotransmitter Receptor Influence on Behavior (44 papers), Neuroscience and Neuropharmacology Research (36 papers) and Synthesis and Biological Evaluation (22 papers). E Tatarczyńska is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (44 papers), Neuroscience and Neuropharmacology Research (36 papers) and Synthesis and Biological Evaluation (22 papers). E Tatarczyńska collaborates with scholars based in Poland, Italy and France. E Tatarczyńska's co-authors include E Chojnacka-Wójcik, Aleksandra Kłodzińska, Andrzej Pilc, Edmund Przegaliński, Agnieszka Nikiforuk, Anna Wesołowska, Katarzyna Stachowicz, Agnieszka Pałucha-Poniewiera, Gabriel Nowak and Beata Duszyńska and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

E Tatarczyńska

90 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E Tatarczyńska Poland	26	1.7k	1.1k	454	409	393	90	2.4k
E Chojnacka-Wójcik Poland	30	2.2k 1.3×	1.5k 1.4×	515 1.1×	497 1.2×	406 1.0×	137	3.1k
J.C. Winter United States	35	2.2k 1.3×	973 0.9×	267 0.6×	441 1.1×	296 0.8×	109	3.2k
Aleksandra Kłodzińska Poland	24	1.4k 0.8×	916 0.8×	333 0.7×	244 0.6×	196 0.5×	70	1.8k
Joseph P. Tizzano United States	20	1.7k 1.0×	1.2k 1.1×	312 0.7×	244 0.6×	202 0.5×	37	2.1k
Thomas P. Blackburn United States	30	2.2k 1.3×	1.6k 1.4×	440 1.0×	330 0.8×	347 0.9×	70	3.6k
Krystyna Gołembiowska Poland	31	1.8k 1.0×	954 0.9×	306 0.7×	189 0.5×	440 1.1×	130	3.0k
Rudy Schreiber Netherlands	30	1.6k 0.9×	1.3k 1.1×	359 0.8×	173 0.4×	508 1.3×	72	2.6k
Karen L. Marquis United States	24	1.1k 0.6×	1.1k 1.0×	217 0.5×	269 0.7×	391 1.0×	44	2.4k
Agnieszka Nikiforuk Poland	31	1.3k 0.8×	1.1k 1.0×	467 1.0×	268 0.7×	598 1.5×	91	2.9k
Michael G. Palfreyman France	32	1.8k 1.0×	1.3k 1.2×	227 0.5×	329 0.8×	362 0.9×	99	3.3k

Countries citing papers authored by E Tatarczyńska

Since Specialization

Citations

This map shows the geographic impact of E Tatarczyńska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Tatarczyńska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Tatarczyńska more than expected).

Fields of papers citing papers by E Tatarczyńska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Tatarczyńska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Tatarczyńska. The network helps show where E Tatarczyńska may publish in the future.

Co-authorship network of co-authors of E Tatarczyńska

This figure shows the co-authorship network connecting the top 25 collaborators of E Tatarczyńska. A scholar is included among the top collaborators of E Tatarczyńska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Tatarczyńska. E Tatarczyńska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Czopek, Anna, Marcin Kołaczkowski, Maciej Pawłowski, et al.. (2009). Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity. European Journal of Medicinal Chemistry. 45(4). 1295–1303. 38 indexed citations

Chłoń‐Rzepa, Grażyna, Paweł Żmudzki, Paweł Zajdel, et al.. (2007). 7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT1A, 5-HT2A, and 5-HT7 serotonin receptor ligands. Bioorganic & Medicinal Chemistry. 15(15). 5239–5250. 20 indexed citations

Zajdel, Paweł, Gilles Subra, Andrzej J. Bojarski, et al.. (2007). Novel class of arylpiperazines containing N-acylated amino acids: Their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation. Bioorganic & Medicinal Chemistry. 15(8). 2907–2919. 22 indexed citations

Wesołowska, Anna, Agnieszka Nikiforuk, Katarzyna Stachowicz, & E Tatarczyńska. (2006). Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology. 51(3). 578–586. 190 indexed citations

Obniska, Jolanta, Krzysztof Kamiński, & E Tatarczyńska. (2006). Impact of aromatic substitution on the anticonvulsant activity of new N-(4-arylpiperazin-1-yl)-alkyl-2-azaspiro[4,5]decane-1,3-dione derivatives.. PubMed. 58(2). 207–14. 26 indexed citations

Kołaczkowski, Marcin, et al.. (2005). Synthesis and 5-HT1A/5-HT2A activity of some butyl analogs in the group of phenylpiperazine alkyl pyrimido[2,1-f]theophyllines.. PubMed. 57(2). 229–35. 17 indexed citations

Obniska, Jolanta, Maciej Pawłowski, Marcin Kołaczkowski, et al.. (2004). Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-beta-tetralonepyrrolidine-2,5-dione.. PubMed. 55(4). 553–7. 14 indexed citations

Tatarczyńska, E, Aleksandra Kłodzińska, & E Chojnacka-Wójcik. (2003). Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats.. PubMed. 54(6). 615–23. 32 indexed citations

Bojarski, Andrzej J., Piotr A. Kowalski, Teresa Kowalska, et al.. (2002). Synthesis and pharmacological evaluation of new arylpiperazines. 3-{4-[4-(3-chlorophenyl)-1-piperazinyl]butyl}-quinazolidin-4-one — a dual serotonin 5-HT1A/5-HT2A receptor ligand with an anxiolytic-like activity. Bioorganic & Medicinal Chemistry. 10(12). 3817–3827. 27 indexed citations

10.

Przegaliński, Edmund, E Tatarczyńska, & E Chojnacka-Wójcik. (2000). The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats. Neuropharmacology. 39(10). 1858–1864. 34 indexed citations

11.

Chojnacka-Wójcik, E, et al.. (1997). Effect of glycine on antidepressant- and anxiolytic-like action of 1-aminocyclopropanecarboxylic acid (ACPC) in rats.. PubMed. 48(6). 627–9. 7 indexed citations

12.

Chojnacka-Wójcik, E, E Tatarczyńska, & Andrzej Pilc. (1997). The anxiolytic-like effect of metabotropic glutamate receptor antagonists after intrahippocampal injection in rats. European Journal of Pharmacology. 319(2-3). 153–156. 45 indexed citations

13.

Przegaliński, Edmund, et al.. (1996). Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors. Pharmacology Biochemistry and Behavior. 54(1). 73–77. 39 indexed citations

14.

Mokrosz, Maria J., E Chojnacka-Wójcik, E Tatarczyńska, et al.. (1995). ChemInform Abstract: Structure‐Activity Relationship Studies of CNS Agents. Part 18. 1‐((2‐ Methoxyphenyl)‐4‐(4‐succinimido)butyl)piperazine (MM‐77): A New, Potent, Postsynaptic Antagonist of 5‐HT1A Receptors.. ChemInform. 26(13). 3 indexed citations

15.

Przegaliński, Edmund, Małgorzata Filip, E Chojnacka-Wójcik, & E Tatarczyńska. (1994). The role of 5-hydroxytryptamine1A (5-HT1A) receptors in the anticonflict activity of β-adrenoceptor antagonists. Pharmacology Biochemistry and Behavior. 47(4). 873–878. 11 indexed citations

16.

Carli, Mirjana, E Tatarczyńska, Luigi Cervo, & R. Samanin. (1993). Stimulation of hippocampal 5-HT1A receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat. European Journal of Pharmacology. 234(2-3). 215–221. 68 indexed citations

17.

Cervo, Luigi, Claudia Rossi, E Tatarczyńska, & R. Samanin. (1992). Antidepressant-like effect of neurotensin administered in the ventral tegmental area in the forced swimming test. Psychopharmacology. 109(3). 369–372. 18 indexed citations

18.

Tatarczyńska, E, Leszek Pawłowski, E Chojnacka-Wójcik, & Joanna Maj. (1990). The central action of 1-(2-pyrimidinyl)-piperazine, an ipsapirone metabolite.. PubMed. 41(1). 51–61. 4 indexed citations

19.

Przewłocka, Barbara, et al.. (1977). The effect of lesions of raphe nuclei on the cataleptic action of neuroleptics.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 29(6). 581–9. 3 indexed citations

20.

Przewłocka, Barbara, et al.. (1977). The effect of lesions of dorsal or median raphe nucleus on rat behavior.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 29(6). 573–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact